Jim Simons Endra Life Sciences Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $319.0 $64,766 - $89.8 Million	-281,593 Reduced 49.92%	282,473 $86,000
Q2 2022 Aug 12, 2022	BUY	$0.19 - $0.45 $40,805 - $96,644	214,766 Added 61.48%	564,066 $132,000
Q1 2022 May 13, 2022	BUY	$0.36 - $0.77 $47,599 - $101,809	132,220 Added 60.91%	349,300 $136,000
Q4 2021 Feb 11, 2022	BUY	$0.69 - $1.73 $149,785 - $375,548	217,080 New	217,080 $150,000
Q1 2021 May 13, 2021	SELL	$0.8 - $2.85 $69,120 - $246,240	-86,400 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$0.69 - $0.9 $59,615 - $77,760	86,400 New	86,400 $65,000
Q3 2020 Nov 13, 2020	SELL	$0.72 - $1.04 $13,212 - $19,084	-18,350 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.63 - $1.1 $11,560 - $20,185	18,350 New	18,350 $18,000

Ticker NDRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 63,174,500
Market Cap $348M
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.